Researcher profile

Charles Stoecker

Charles Stoecker contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2021arXiv

Modelling the Impact of Screening Men for Chlamydia Trachomatis on the Prevalence in Women

Chlamydia trachomatis is the most commonly reported infectious disease in the United States and causes important reproductive morbidity in women. The Centers for Disease Control and Prevention have recommended routine screening of sexually active women under age 25 but have not recommended screening among men. Consequently, untested and untreated men may serve as a reservoir of infection in women. Despite three decades of screening women, the chlamydia prevalence has continued to increase. Moreover, chlamydia is five times more common in African American (AA) youth compared to Whites, constituting an important health disparity. The Check It program is a bundled Ct intervention targeting AA men aged 15-24 who have sex with women. We created an individual-based network model to simulate a realistic chlamydia epidemic on sexual contact networks for the target population. Based on the practice in Check It, we quantified the impact of screening young AA men on the chlamydia prevalence in women. We used sensitivity analysis to quantify the relative importance of each Check It intervention component, and the significance ranked from high to low was venue-based screening, expedited index treatment, expedited partner treatment, rescreening. We estimated that by annually screening 7.5% of the target male population, the chlamydia prevalence would be reduced by 8.1% and 8.8% in men and women, respectively. The findings suggested that male-screening has the potential to significantly reduce the prevalence among women.